E09.339
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code E09.339 refers to a specific type of diabetes mellitus caused by drug or chemical exposure. This condition also involves moderate nonproliferative diabetic retinopathy, a common eye complication associated with diabetes, but notably without macular edema. Recognizing this diagnosis helps in managing both the underlying cause of diabetes and its ocular effects.
Causes & Symptoms
Clinical Causes: Use of certain medications, such as glucocorticoids or other drugs known to elevate blood sugar levels Exposure to chemicals or toxins that interfere with insulin function or glucose metabolism Underlying health conditions that may trigger drug-induced diabetes as a side effect
Key Symptoms: Elevated blood sugar levels detected through laboratory tests Increased thirst and urination Fatigue and weakness Blurred vision or visual disturbances Signs of eye damage, such as changes in vision without pain
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to measure glucose levels and HbA1c. Ophthalmologic evaluation confirms the presence and severity of diabetic retinopathy. The healthcare provider may review medication history to identify possible drug-related causes of elevated blood sugar.
Treatment Protocols: Management includes adjusting or discontinuing the causative medication under medical supervision, controlling blood sugar levels through diet, exercise, and possibly medication, and monitoring eye health. Regular ophthalmologic exams are recommended to assess the progression of diabetic retinopathy.
Clinical Advice & FAQs
Billing Guidance
Is E09.339 a billable ICD-10 code?
Yes, E09.339 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.339?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference